Table 2 Proportion of PWID reporting overdose outcomes stratified by reported presumed xylazine effects
Past 12-month outcomes | Overdose experience | Used Narcan | Witnessed overdose | Knows someone who died overdose | Abscess/wound requiring medical attention | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
No % | Yes % | No % | Yes % | No % | Yes % | No % | Yes % | No % | Yes % | ||
Xylazine effect | No (n = 37) | 44 | 17 | 51 | 21 | 61 | 27 | 67 | 34 | 44 | 25 |
Yes (n = 59) | 56 | 83 | 49 | 79 | 39 | 73 | 33 | 66 | 56 | 75 | |
Xylazine by name | Xylazine effect | No % | Yes % | No % | Yes % | No % | Yes % | No % | Yes % | No % | Yes % |
No (n = 57) | No (n = 29) | 56 | 20 | 58 | 35 | 63 | 40 | 67 | 47 | 55 | 38 |
Yes (n = 28) | 43 | 80 | 43 | 65 | 37 | 60 | 33 | 53 | 45 | 62 | |
Yes (n = 34) | No (n = 6) | 17 | 20 | 33 | 5 | 50 | 11 | 0 | 18 | 21 | 13 |
Yes (n = 28) | 83 | 80 | 67 | 95 | 50 | 89 | 0 | 82 | 79 | 87 | |
Fentanyl frequency | Xylazine effect | No % | Yes % | No % | Yes % | No % | Yes % | No % | Yes % | No % | Yes % |
None (n = 17) | No (n = 13) | 80 | 50 | 80 | 50 | 85 | 50 | 100 | 71 | 0 | 76 |
Yes (n = 4) | 20 | 50 | 20 | 50 | 15 | 50 | 0 | 28 | 0 | 24 | |
Less than daily (n = 41) | No (n = 15) | 42 | 20 | 52 | 20 | 50 | 32 | 75 | 32 | 34 | 38 |
Yes (n = 26) | 58 | 80 | 48 | 80 | 50 | 68 | 25 | 68 | 64 | 62 | |
Daily (n = 37) | No (n = 9) | 31 | 9 | 30 | 18 | 44 | 18 | 60 | 19 | 32 | 13 |
Yes (n = 28) | 69 | 91 | 70 | 82 | 56 | 82 | 40 | 81 | 68 | 87 | |